Thyroxine-induced expression of pyroglutamyl peptidase II and inhibition of TSH release precedes suppression of TRH mRNA and requires type 2 deiodinase

Journal of Endocrinology

Volumn 211, Issue 1, 2011, Pages 73-78

  Marsili, Alessandro ^a   Sanchez, Edith ^b,c   Singru, Praful ^b,d   Harney, John W ^a   Zavacki, Ann Marie ^a   Lechan, Ronald M ^b   Larsen, P R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^d NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEIODINASE 2; MESSENGER RNA; PEPTIDE HYDROLASE; PEROXIDASE; PROTIRELIN; PYROGLUTAMYL PEPTIDASE 2; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; AMINOPEPTIDASE; ANTITHYROID AGENT; DRUG DERIVATIVE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II; LIOTHYRONINE; PYROGLUTAMIC ACID; PYROGLUTAMYL PEPTIDASE II; PYROGLUTAMYL-PEPTIDASE II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONOLOGY; CONTROLLED STUDY; ENZYME BLOOD LEVEL; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANYCYTE; THYROTROPIN RELEASE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; HYPOTHYROIDISM; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PATHOLOGY;

AMINOPEPTIDASES; ANIMALS; ANTITHYROID AGENTS; DISEASE MODELS, ANIMAL; HYPOTHYROIDISM; INJECTIONS, INTRAPERITONEAL; IODIDE PEROXIDASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PYRROLIDONECARBOXYLIC ACID; RNA, MESSENGER; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE; TRIIODOTHYRONINE;

EID: 80555125118     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0248     Document Type: Article

References (30)

1. Bowers CY, Lee KL & Schally AV 1968a Effect of actinomycin D on hormones that control the release of thyrotropin from the anterior pituitary glands of mice. Endocrinology 82 303-310. (doi:10.1210/endo-82-2-303)
2. Bowers CY, Lee KL & Schally AV 1968b A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: effects of puromycin and cycloheximide. Endocrinology 82 75-82. (doi:10.1210/endo-82-1-75)
3. Charli JL, Vargas MA, Cisneros M, de Gortari P, Baeza MA, Jasso P, Bourdais J, Perez L, Uribe RM & Joseph-Bravo P 1998 TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II. Neurobiology 6 45-57.
4. Chiamolera MI & Wondisford FE 2009 Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150 1091-1096. (doi:10.1210/en.2008-1795)
5. Christoffolete MA, Arrojo e Drigo R, Gazoni F, Tente SM, Goncalves V, Amorim BS, Larsen PR, Bianco AC & Zavacki AM 2007 Mice with impaired extrathyroidal thyroxine to 3,5,3'-triiodothyronine conversion maintain normal serum 3,5,3'-triiodothyronine concentrations. Endocrinology 148 954-960. (doi:10.1210/en.2006-1042)
6. Cruz R, Vargas MA, Uribe RM, Pascual I, Lazcano I, Yiotakis A, MatziariM, Joseph-Bravo P & Charli JL 2008 Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release. Peptides 29 1953-1964. (doi:10.1016/j.peptides.2008.07.011)
7. Fekete C & Lechan RM 2007 Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Frontiers in Neuroendocrinology 28 97-114. (doi:10.1016/j.yfrne.2007.04.002)
8. Foord SM, Peters JR, Dieguez C, Jasani B, Hall R & Scanlon MF 1984 Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding. Endocrinology 115 407-415. (doi:10.1210/endo-115-1-407)
9. Heuer H, Ehrchen J, Bauer K & Schafer MK 1998 Region-specific expression of thyrotrophin-releasing hormone-degrading ectoenzyme in the rat central nervous system and pituitary gland. European Journal of Neuroscience 10 1465-1478. (doi:10.1046/j.1460-9568.1998.00158.x)
10. Heuer H, Schafer MK, O'Donnell D, Walker P & Bauer K 2000 Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. Journal of Comparative Neurology 428 319-336. (doi:10.1002/1096-9861(20001211)428:2<319::AID-CNE10O>3.0. CO;2-9)
11. Kadar A, Sanchez E, Wittmann G, Singru PS, Fuzesi T, Marsili A, Larsen PR, Liposits Z, Lechan RM & Fekete C 2010 Distribution of hypophysiotropic thyrotropin-releasing hormone (TRH)-synthesizing neurons in the hypothalamic paraventricular nucleus of the mouse. Journal of Comparative Neurology 518 3948-3961. (doi:10.1002/cne.22432)
12. Kakucska I, Rand W & Lechan RM 1992 Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine. Endocrinology 130 2845-2850. (doi:10.1210/en.130.5.2845)
13. Larsen PR, Dick TE, Markovitz BP, Kaplan MM & Gard TG 1979 Inhibition of intrapituitary thyroxine to 3,5,3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. Journal of Clinical Investigation 64 117-128. (doi:10.1172/JCI109430)
14. Larsen PR, Silva JE & Kaplan MM 1981 Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocrine Reviews 2 87-102. (doi:10.1210/edrv-2-1-87)
15. Lechan RM & Fekete C 2005 Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15 883-897. (doi:10.1089/thy.2005.15.883)
16. Levy A, Matovelle MC, Lightman SL & Young WS III 1992 The effects of pituitary stalk transection, hypophysectomy and thyroid hormone status on insulin-like growth factor 2-, growth hormone releasing hormone-, and somatostatin mRNA prevalence in rat brain. Brain Research 579 1-7. (doi:10.1016/0006-8993(92)90735-R)
17. Marsili A, Ramadan W, Harney JW, Mulcahey M, Castroneves LA, Goemann IM, Wajner SM, Huang SA, Zavacki AM, Maia AL et al. 2010 Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism. Endocrinology 151 5952-5960. (doi:10.1210/en.2010-0631)
18. Nikrodhanond AA, Ortiga-Carvalho TM, Shibusawa N, Hashimoto K, Liao XH, Refetoff S, Yamada M, Mori M & Wondisford FE 2006 Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. Journal of Biological Chemistry 281 5000-5007. (doi:10.1074/jbc.M511530200)
19. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J & Refetoff S 1999 Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid 9 1265-1271. (doi:10.1089/thy.1999.9.1265)
20. Riskind PN, Kolodny JM & Larsen PR 1987 The regional hypothalamic distribution of type II 5'-monodeiodinase in euthyroid and hypothyroid rats. Brain Research 420 194-198. (doi:10.1016/0006-8993(87)90260-5)
21. Sanchez E, Vargas MA, Singru PS, Pascual I, Romero F, Fekete C, Charli JL & Lechan RM 2009 Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence. Endocrinology 150 2283-2291. (doi:10.1210/en.2008-1643)
22. 4. Molecular Endocrinology 15 2137-2148. (doi:10.1210/me.15.12.2137)
23. Segerson TP, Kauer J, Wolfe HC, Mobtaker H, Wu P, Jackson IM & Lechan RM 1987 Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 238 78-80. (doi:10.1126/science.3116669)
24. Shupnik MA, Ridgway EC & Chin WW 1989 Molecular biology of thyrotropin. Endocrine Reviews 10 459-475. (doi:10.1210/edrv-10-4-459)
25. Silva JE & Larsen PR 1977 Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science 198 617-620. (doi:10.1126/science.199941).
26. Silva JE & Larsen PR 1978 Peripheral metabolism of homologous thyrotropin in euthyroid and hypothyroid rats: acute effects of thyrotropin-releasing hormone, triiodothyronine, and thyroxine. Endocrinology 102 1783-1796. (doi:10.1210/endo-102-6-1783)
27. Sugrue ML, Vella KR, Morales C, Lopez ME & Hollenberg AN 2010 The thyrotropin-releasing hormone gene is regulated by thyroid hormone at the level of transcription in vivo. Endocrinology 151 793-801. (doi:10.1210/en. 2009-0976)
28. Tam SP, Lam KS & Srivastava G 1996 Gene expression of hypothalamic somatostatin, growth hormone releasing factor, and their pituitary receptors in hypothyroidism. Endocrinology 137 418-424. (doi:10.1210/en.137.2.418)
29. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR & LechanRM 1997 Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138 3359-3368. (doi:10.1210/en.138.8. 3359)
30. Vale W, Burgus R & Guillemin R 1968 On the mechanism of action of TRF: effects of cycloheximide and actinomycin on the release of TSH stimulated in vitro by TRF and its inhibition by thyroxine. Neuroendocrinology 3 34-46. (doi:10.1159/000121692)